Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients

S. Canestri, M.C. Totaro, E. Serone, B. Tolusso, D. Frezza, E. Gremese, G. Ferraccioli

368-373

20-12-2012

https://doi.org/10.4081/reumatismo.2012.368

2289

PDF: 847
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient

C. Bruni, S. Bellando-Randone, L. Gargani, E. Picano, A. Pingitore, M. Matucci-Cerinic, S. Guiducci

109-111

09-09-2016

https://doi.org/10.4081/reumatismo.2016.889

1937

PDF: 1227
Chronic widespread pain in spondyloarthritis

F. Atzeni, L. Boccassini, M. Di Franco, A. Alciati, A. Marsico, M. Cazzola, G. Cassisi, P. Sarzi-Puttini

28-32

06-06-2014

https://doi.org/10.4081/reumatismo.2014.761

2758

PDF: 1668
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio

08-05-2023

https://doi.org/10.4081/reumatismo.2023.1559

1805

PDF: 966
Development of thymoma without myasthenia gravis in a patient with radiographic axial spondyloarthritis treated with tumor necrosis factor-α inhibitors

Piera Altieri, Francesco Maria Mariani, Evy Di Ruscio, Francesco Carubbi, Claudio Ferri, Alessia Alunno

05-06-2025

https://doi.org/10.4081/reumatismo.2025.1693

2146

PDF: 40
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections

A. Laria, A. Zoli, E. Gremese, G.F. Ferraccioli

5-10

https://doi.org/10.4081/reumatismo.2011.5

2389

PDF: 1826
Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients

F. Cacciapaglia, M.G. Anelli, D. Rizzo, E. Morelli, C. Scioscia, D. Mazzotta, F. Iannone, G. Lapadula

97-102

09-02-2016

https://doi.org/10.4081/reumatismo.2015.829

2282

PDF: 1311
Psoriatic arthritis: treatment strategies using biologic agents

S. D'Angelo, C. Palazzi, I. Olivieri

113-121

05-06-2012

https://doi.org/10.4081/reumatismo.2012.113

1333

PDF: 1190
Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera

13-01-2025

https://doi.org/10.4081/reumatismo.2025.1718

1558

PDF: 135

SUPPLEMENTARY MATERIAL: 124
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review

Liala Moschetti, Francesca Crisafulli, Francesca Regola, Rossana Orabona, Sofia Pitsigavdaki, Franco Franceschini, Laura Andreoli, Sonia Zatti, Angela Tincani

29-07-2025

https://doi.org/10.4081/reumatismo.2025.1835

825

PDF: 168
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

29-01-2025

https://doi.org/10.4081/reumatismo.2025.1754

1674

PDF: 258

SUPPLEMENTARY MATERIAL: 123
The treatment of recurrent uveitis with TNFα inhibitors

P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

185-189

https://doi.org/10.4081/reumatismo.2004.185

1797

PDF: 2422
Antisynthetase syndrome with anti-glycyl tRNA synthetase antibodies in a patient with axial spondyloarthritis treated with tumor necrosis factor-α inhibitors

Maria Iacovantuono, Chiara Bonini, Ernesto Di Biase, Vinicio Magliacani, Gian Domenico Sebastiani

10-02-2025

https://doi.org/10.4081/reumatismo.2025.1756

1131

PDF: 177
Janus kinase inhibitors: between prescription authorization and reimbursability

F.R. Spinelli, F. Conti, R. Caporali, F. Iannone, F. Cacciapaglia, on behalf of the Steering Committee of the Italian Society of Rheumatology

19-12-2023

https://doi.org/10.4081/reumatismo.2023.1627

1277

PDF: 320
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

17-07-2023

https://doi.org/10.4081/reumatismo.2023.1544

1186

PDF: 638
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors

Cristina Garufi, Silvia Mancuso, Fulvia Ceccarelli, Letizia Caruso, Cristiano Alessandri, Manuela Di Franco, Roberta Priori, Valeria Riccieri, Rossana Scrivo, Simona Truglia, Fabrizio Conti, Francesca Romana Spinelli

05-11-2024

https://doi.org/10.4081/reumatismo.2024.1725

2367

PDF: 297
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

52-59

10-04-2020

https://doi.org/10.4081/reumatismo.2020.1266

2101

PDF: 1215
Treatment of hyperuricemia, gout and other crystalline arthritidies

F. Lioté

276-283

https://doi.org/10.4081/reumatismo.2011.276

1256

PDF: 1186
The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease

Ennio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, Carla Felice, Fabio Massimo Perrotta, Vincenzo Venerito, Sergio Del Vescovo, Roberta Ramonda, Giulia Cassone, Fabiola Atzeni, Roberto Caporali, Fabrizio Conti, Elisa Gremese, Florenzo Iannone, Marco Sebastiani, Ennio Giulio Favalli

11-11-2024

https://doi.org/10.4081/reumatismo.2024.1688

1777

PDF: 369
Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice

G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini

261-267

https://doi.org/10.4081/reumatismo.2006.261

1247

PDF: 736
Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

Dario Camellino, Christian Dejaco, Franco Martini, Renzo Cosso, Gerolamo Bianchi

28-10-2024

https://doi.org/10.4081/reumatismo.2024.1796

1760

PDF: 351
Differences in pharmacology of tumor necrosis factor (TNF) antagonists

U. Fiocco, S. Bombardieri

8-16

https://doi.org/10.4081/reumatismo.2005.4s.8

1189

PDF: 1781
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

29-12-2022

https://doi.org/10.4081/reumatismo.2022.1511

1997

PDF: 874
Pharmacological treatment of fibromyalgia

M. Cazzola, P. Sarzi-Puttini, D. Buskila, F. Atzeni

280-291

https://doi.org/10.4081/reumatismo.2007.280

2886

PDF: 4924
Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review

Carlo Perricone, Roberto Dal Pozzolo, Giacomo Cafaro, Santina Calvacchi, Lorenza Bruno, Francesco Tromby, Anna Colangelo, Roberto Gerli, Elena Bartoloni

25-10-2024

https://doi.org/10.4081/reumatismo.2024.1685

2052

PDF: 445
Pain patterns in italian patients with osteoarthritis: preliminary results of the MI.D.A. Study (Misurazione del Dolore nell’Artrosi)

M.A. Cimmino, F. Salaffi, I. Olivieri, F. Trotta, P. Sarzi Puttini, W. Grassi, V. Modena, F.P. Cantatore, S. Bombardieri, S. Adami, L. Punzi, G. Lapadula, Gruppo MI.D.A.

253-261

https://doi.org/10.4081/reumatismo.2004.253

2377

PDF: 6383
Therapy of rheumatic polymyalgia: the pathophysiologic management

M. Cutolo, M. Olivieri, M.E. Secchi, M.A. Cimino

271-279

https://doi.org/10.4081/reumatismo.2007.271

1512

PDF: 2122
Adult-onset systemic autoinflammatory disorders: a clinical approach

T. Borges, A. Barbosa, S. Silva

177-188

28-01-2020

https://doi.org/10.4081/reumatismo.2019.1192

4276

PDF: 2510
Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFα treatment

M. Di Gangi, R. Foti, R. Leonardi, C. Leonetti, P. Castellino

169-172

https://doi.org/10.4081/reumatismo.2007.169

1041

PDF: 990
The impact of nicotine smoking on spondyloarthritis and rheumatoid arthritis

G. El Hasbani, J. E Nassar, A.M. Elsayed Ali, I. Uthman, A. Jawad

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1572

4984

PDF: 1623
Pathophysiology of osteoarthritis: perspectives

S. Adami, O. Viapiana

18-25

https://doi.org/10.4081/reumatismo.2001.18

1964

PDF: 1560
Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)

M.T. Riccardi, A. Chialà, F. Iannone, V. Grattagliano, M. Covelli, G. Lapadula

135-139

https://doi.org/10.4081/reumatismo.2007.135

1186

PDF: 783
Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report

V.F. Azevedo, C.F. Pietrovski, M. de Almeida Santos Jr

283-285

https://doi.org/10.4081/reumatismo.2010.283

1355

PDF: 1303
Early rheumatoid arthritis

F. Atzeni, P. Sarzi-Puttini

100-117

https://doi.org/10.4081/reumatismo.2007.100

1518

PDF: 2119
A short history of anti-rheumatic therapy. III. Non steroidal anti-inflammatory drugs

G. Pasero, P. Marson

225-232

https://doi.org/10.4081/reumatismo.2010.225

1676

PDF: 1216
Septic arthritis: a 12 years retrospective study in a rheumatological university clinic

M. Favero, F. Schiavon, L. Riato, V. Carraro, L. Punzi

260-267

https://doi.org/10.4081/reumatismo.2008.260

1632

PDF: 1469

1 - 36 of 36 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy